Institut für Pathophysiologie, Universitätsklinikum Essen, Essen, Germany.
Circ J. 2011;75(2):229-36. doi: 10.1253/circj.cj-10-0925. Epub 2010 Oct 28.
Resting heart rate (HR) is increased in patients with heart failure (HF). Sustained tachycardia can cause HF. The magnitude of HR reduction in treatment trials of patients with HF is associated with a reduction in mortality. Yet, the mechanistic and causal role of HR in HF is unclear, and recent trials with selective HR reduction have not consistently achieved benefit: the BEAUTIFUL trial in patients with coronary artery disease and left ventricular dysfunction did not achieve a significant benefit in the primary endpoint, and only the coronary outcome, not the HF outcome, was improved; in the SHIFT trial, however, patients with symptomatic heart failure had a significant benefit in the primary endpoint of cardiovascular mortality and hospitalization for worsening HF. The present review addresses the pathophysiology of tachycardia-induced HF, the force-frequency relationship, and the clinical potential of HR reduction in HF.
静息心率(HR)在心力衰竭(HF)患者中增加。持续的心动过速可导致 HF。HF 患者治疗试验中 HR 降低的幅度与死亡率降低相关。然而,HR 在 HF 中的机制和因果作用尚不清楚,并且最近的选择性 HR 降低试验并未一致获得益处:在伴有左心室功能障碍的冠状动脉疾病患者中的 BEAUTIFUL 试验中,主要终点未达到显著益处,只有冠状动脉结果而不是 HF 结果得到改善;然而,在 SHIFT 试验中,有症状性心力衰竭的患者在心血管死亡率和因 HF 恶化而住院的主要终点方面有显著益处。本综述讨论了心动过速引起的 HF 的病理生理学、力频率关系以及 HR 降低在 HF 中的临床潜力。